Aetna Sets New 12-Month High at $72.42 (AET)
Aetna (NYSE:AET) shares reached a new 52-week high on Monday , American Banking & Market News reports. The company traded as high as $72.42 and last traded at $72.18, with a volume of 2,009,439 shares trading hands. The stock had previously closed at $70.43.
AET has been the subject of a number of recent research reports. Analysts at Cantor Fitzgerald raised their price target on shares of Aetna to $75.00 in a research note on Monday, February 10th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Aetna in a research note on Friday, February 7th. They now have a $71.00 price target on the stock. Finally, analysts at Leerink Swann upgraded shares of Aetna from a “market perform” rating to an “outperform” rating in a research note on Thursday, February 6th. Three analysts have rated the stock with a hold rating, twenty have issued a buy rating and one has issued a strong buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and a consensus target price of $74.55.
The stock has a 50-day moving average of $68.95 and a 200-day moving average of $65.99. The company has a market cap of $26.006 billion and a P/E ratio of 13.21.
Aetna (NYSE:AET) last announced its earnings results on Thursday, February 6th. The company reported $1.34 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.36 by $0.02. The company had revenue of $13.13 billion for the quarter, compared to the consensus estimate of $13.14 billion. During the same quarter last year, the company posted $0.94 earnings per share. Aetna’s revenue was up 46.7% compared to the same quarter last year. On average, analysts predict that Aetna will post $6.37 earnings per share for the current fiscal year.
In other Aetna news, VP Rajan Parmeswar sold 3,600 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $69.46, for a total value of $250,056.00. Following the completion of the transaction, the vice president now directly owns 3,829 shares of the company’s stock, valued at approximately $265,962. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.
Aetna Inc (NYSE:AET) is a diversified healthcare benefits company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.